| Re:Russland lässt Impfstoff ohne umfangreiche Tests zu. |  |
Phase 3 beginnt morgen und die Massenproduktion nächsten Monat. Es sind jetzt wohl über 20 Länder an dem Impfstoff interessiert.
Phase 3 clinical trial involving more than 2,000 people in Russia, a number of Middle Eastern (UAE and Saudi Arabia), and Latin American countries (Brazil and Mexico) will start on August 12. The vaccine has received a registration certificate from the Russian Ministry of Health on August 11 and under emergency rules adopted during the COVID-19 pandemic can be used to vaccinate the population in Russia. Mass production of the vaccine is expected to start in September 2020.
[https://sputnikvaccine.com/about-vaccine/clinical-trials/]